Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:INT ISPE - GPP Revision 3 (2015): Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
Migrate to Template:DocumentData for PageForms (GxPlexBot)
Line 1: Line 1:
<noinclude>{{#set:
{{DocumentData
|DocReference=INT  ISPE - GPP  Revision 3 (2015)
|DocValidityArea=INT
|DocScopes=INS
|DocName=ISPE - GPP
|DocVersion=Revision 3 (2015)
|DocStatus=Current
|DocType=International guideline
|DocLanguage=EN
|DocDescription=Guidelines for Good Pharmacoepidemiology Practices (GPP)
International Society for Pharmacoepidemiology (ISPE)
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>
 
{{DocumentBox
|reference=INT  ISPE - GPP  Revision 3 (2015)
|reference=INT  ISPE - GPP  Revision 3 (2015)
|validity_area=INT
|validity_area=INT

Revision as of 12:54, 16 July 2026


Document information
Reference INT ISPE - GPP Revision 3 (2015)
Validity area INT
Scope(s) INS
Document name ISPE - GPP
Version / Revision Revision 3 (2015)
Status Current
Document type International guideline
Language(s) EN
Description Guidelines for Good Pharmacoepidemiology Practices (GPP)

International Society for Pharmacoepidemiology (ISPE)

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
INT ISPE - GPP Revision 3 (2015) -INS-ENGuidelines for Good Pharmacoepidemiology Practices (GPP)

International Society for Pharmacoepidemiology (ISPE)

https://www.pharmacoepi.org/resources/…
INT ISPE - GPP Revision 3 (2015) II.INSII.ENII. Protocol Development [...]…


References

Reference Scope Document part Language Preview
Reference:INT ISPE - GPP Revision 3 (2015) - INS - EN Guidelines for Good Pharmacoepidemiology Practices (GPP) International Society for Pharmacoepidemiology (ISPE) https://www.pharmacoepi.org/resources/policies/guidelines-08027/
Reference:INT ISPE - GPP Revision 3 (2015) II. INS II. EN II. Protocol Development [...]